Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€108.80

€108.80

-0.950%
-1.05
-0.950%
€126.06

€126.06

 
23.12.25 / Tradegate WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Stock / ? /
Latest predictions
22.12.25
-3.63%
buy
€142.46
08.12.25
-7.40%
buy
€120.54
30.10.25
-6.85%
buy
€124.79
13.10.25
13.07%
buy
18.09.25
7.87%
buy
€131.72
16.09.25
11.52%
buy
Best running prediction
€92.19
29.04.25
36.24%
buy
Your prediction

Transmedics Group Inc Stock

The price for the Transmedics Group Inc stock decreased slightly today. Compared to yesterday there is a change of -€1.050 (-0.950%).
With 12 Buy predictions and not the single Sell prediction the community is currently very high on Transmedics Group Inc.
With a target price of 126 € there is a slightly positive potential of 15.81% for Transmedics Group Inc compared to the current price of 108.8 €.
So far the community has only identified positive things for Transmedics Group Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Transmedics Group Inc in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

TransMedics Group (NASDAQ:TMDX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -7.40%
Target price 142.461
Change
Ends at 08.12.26

TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Needham & Company LLC from $148.00 to $166.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -6.85%
Target price 120.540
Change
Ends at 30.10.26

TransMedics Group (NASDAQ:TMDX) had its price target lowered by analysts at Piper Sandler from $145.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more